Osei, K <br/><br/>
Metabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy.  [electronic resource] 

 -  Diabetes  Jun 1989 
 - 704-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0012-1797 
<br/><br/><label>Standard No.: </label>10.2337/diab.38.6.704  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Glucose--metabolism<br/>Circadian Rhythm<br/>Clinical Trials as Topic<br/>Diabetes Mellitus, Type 1--blood<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Glucagon--blood<br/>Glycated Hemoglobin--analysis<br/>Growth Hormone--blood<br/>Humans<br/>Insulin--blood<br/>Lipids--blood<br/>Male<br/>Octreotide--adverse effects<br/>Random Allocation